Why some high-risk patients aren't getting drugs to combat COVID
Antiviral medications have remained underused. A group of researchers wanted to know why — and what could be done about it.
Source: voicenews.com
Page 2 - Cooperative Studies Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cooperative Studies Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cooperative Studies Program Today - Breaking & Trending Today
Meds Rarely Offered for COVID-19 Patients at High Risk for Progression
No reason other than mild symptoms given for almost half of patients at high risk for progression who were not offered treatment.
Source: clinicaladvisor.com
Why high-risk patients aren't getting anti-COVID drugs
Medicines such as Paxlovid were hailed as an important way to help reduce the risk of severe illness or death from COVID-19. A new study explores why many vulnerable patients didn't get them.
Source: latimes.com
Here's why some high-risk patients aren't getting drugs to combat COVID
Medicines such as Paxlovid were hailed as an important way to help reduce the risk of severe illness or death from COVID-19. A new study explores why many vulnerable patients didn't get them.
Source: yahoo.com
IRLAB Signs Phase III Regulatory US Consultants to Support Preparation ...
IRLAB Signs Phase III Regulatory US Consultants to Support Preparation ...
Source: pr-inside.com